Answers are grounded in this paper and cite their sources.
Our data show that nanomicelle curcumin is an effective agent in the prevention of OM or reducing its severity. Thus, the administration of nanocurcumin can be considered as a reasonable approach to hinder the development of OM in HNC patients requiring radiotherapy.
No takes yet. Share an insight, caveat, or question.
Delavarian et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: